{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T08:07:39Z","timestamp":1666080459293},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"44","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,21]]},"DOI":"10.1093\/eurheartj\/ehz847","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T09:03:28Z","timestamp":1574327008000},"page":"3579-3582","source":"Crossref","is-referenced-by-count":2,"title":["Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes"],"prefix":"10.1093","volume":"40","author":[{"given":"Thomas F","family":"L\u00fcscher","sequence":"first","affiliation":[{"name":"Professor of Cardiology, Imperial College and Director of Research, Education & Development, Royal Brompton and Harefield Hospitals London, UK"},{"name":"Professor and Chairman, Center for Molecular Cardiology, University of Zurich, Switzerland"},{"name":"Editor-in-Chief, EHJ Editorial Office, Zurich Heart House, Hottingerstreet 14, 8032 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"2019112104010341900_ehz847-B1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B2","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1093\/eurheartj\/ehx525","article-title":"The effect of sacubitril\/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study","volume":"38","author":"Schmieder","year":"2017","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/eurheartj\/ehv467","article-title":"Enhancement patterns detected by multidetector computed tomography are associated with microvascular obstruction and left ventricular remodelling in patients with acute myocardial infarction","volume":"37","author":"Watabe","year":"2016","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1753944717711139","article-title":"Challenges in management of left ventricular thrombus","volume":"11","author":"Habash","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2019112104010341900_ehz847-B5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"key":"2019112104010341900_ehz847-B6","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz427","article-title":"A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial","volume":"40","author":"Mehra","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B7","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz523","article-title":"Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort?","volume":"40","author":"Maggioni","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B8","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1093\/eurheartj\/ehy621","article-title":"Association between renin\u2013angiotensin system inhibitor use and mortality\/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study","volume":"39","author":"Savarese","year":"2018","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B9","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","article-title":"Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study","volume":"38","author":"Ouwerkerk","year":"2017","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B10","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/eurheartj\/ehv273","article-title":"Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial","volume":"36","author":"Girerd","year":"2015","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"Solomon","year":"2016","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B12","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/eurheartj\/ehw132","article-title":"A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease","volume":"37","author":"Filippatos","year":"2016","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B13","first-page":"104","article-title":"Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data","volume":"38","author":"Krogager","year":"2017","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B14","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1093\/eurheartj\/ehx460","article-title":"Associations of serum potassium levels with mortality in chronic heart failure patients","volume":"38","author":"Aldahl","year":"2017","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B15","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz554","article-title":"Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial","volume":"40","author":"Rohde","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B16","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz679","article-title":"Must I keep taking all these medicines? Optimizing diuretics in chronic heart failure","volume":"40","author":"Felker","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B18","first-page":"362","article-title":"Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure","volume":"38","author":"Haddad","year":"2017","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B19","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2019112104010341900_ehz847-B20","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz680","article-title":"Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use","volume":"40","author":"van der Wal","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B21","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/eurheartj\/ehz238","article-title":"Very long-term survival and late sudden cardiac death in cardiac resynchronization therapy patients","volume":"40","author":"Barra","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B22","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/eurheartj\/ehz109","article-title":"Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I","volume":"40","author":"Leclercq","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B23","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz584","article-title":"Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study","volume":"40","author":"Tayal","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B24","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz715","article-title":"Pacing-induced cardiomyopathy: just the tip of the iceberg?","volume":"40","author":"Merchant","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B25","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B26","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/eurheartj\/ehr026","article-title":"Cardiac inotropes: current agents and future directions","volume":"32","author":"Hasenfuss","year":"2011","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B27","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy600","article-title":"Treatments targeting inotropy","volume":"40","author":"Maack","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B28","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/13543784.2016.1123248","article-title":"Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure","volume":"25","author":"Liu","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"2019112104010341900_ehz847-B30","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz655","article-title":"Conversion to and maintenance of sinus rhythm do not yield a significant increase in stroke-volume in HFREF patients, whose heart works on the flat branch of Frank\u2013Starling curve, thereby making the retrieval of the atrial mechanical contribution in this subset a substantially futile choice","volume":"40","author":"De Vecchis","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/eurheartj\/ehy778","article-title":"Atrial fibrillation ablation in heart failure","volume":"40","author":"Richter","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B32","article-title":"Atrial fibrillation ablation in heart failure: it\u2019s not all about Starling my darling","volume":"40","author":"Richter","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B33","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz806","article-title":"Late repercussions of assisted reproductive technology","volume":"40","author":"Messerli","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B34","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/eurheartj\/ehz025","article-title":"Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood","volume":"40","author":"Bavineni","year":"2019","journal-title":"Eur Heart J"},{"key":"2019112104010341900_ehz847-B35","article-title":"Response to \u2018Late repercussions of assisted reproductive technology\u2019","volume":"40","author":"Mehta","year":"2019","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/44\/3579\/31062483\/ehz847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/44\/3579\/31062483\/ehz847.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T09:03:48Z","timestamp":1574327028000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/44\/3579\/5634090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":35,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2019,11,21]]},"published-print":{"date-parts":[[2019,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehz847","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11,21]]},"published":{"date-parts":[[2019,11,21]]}}}